Maloy; W. Lee

Patent Applications and Registrations

Patent applications and USPTO patent grants for Maloy; W. Lee.The latest application filed is for "aminosteroids for the treatment of a ptp1b associated disease".

Company Profile

3.13.12

Maloy; W. Lee - Lansdale PA
Maloy; W. Lee - Larsdale PA
Maloy; W. Lee - Plymouth Meeting PA
Maloy; W. Lee - Landsdale PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Aminosteroids for the treatment of a PTP1B associated disease Grant 11,434,257 - McLane , et al. September 6, 2	2022-09-06
Aminosteroids for the Treatment of a PTP1B Associated Disease App 20200270300 - McLane; Michael ; et al.	2020-08-27
Aminosteroids for the treatment of a PTP1B associated disease Grant 10,556,923 - McLane , et al. Feb	2020-02-11
Aminosteroids for the Treatment of a PTP1B Associated Disease App 20190202858 - McLane; Michael ; et al.	2019-07-04
Aminosteroids for the Treatment of a PTP1B Associated Disease App 20170129914 - McLane; Michael ; et al.	2017-05-11
Aminosteroids for the treatment of a PTP1B associated disease Grant 9,546,194 - McLane , et al. January 17, 2	2017-01-17
Aminosteroids for the Treatment of a PTP1B Associated Disease App 20150099727 - McLane; Michael ; et al.	2015-04-09
Asthma Associated Factors as Targets for Treating Atopic Allergies Including Asthma and Related Disorders App 20110224153 - Levitt; Roy Clifford ; et al.	2011-09-15
Interleukin-9 mutein peptides Grant 7,700,088 - Levitt , et al. April 20, 2	2010-04-20
Asthma associated factors as targets for treating atopic allergies including asthma and related disorders App 20090068185 - Holroyd; Kenneth J. ; et al.	2009-03-12
Antibodies against inducible TH2 cell factors App 20080096981 - Dong; Charles Qu ; et al.	2008-04-24
Interleukin-9 mutein peptides App 20080039401 - Levitt; Roy Clifford ; et al.	2008-02-14
Methods for treating ICACC protein associated diseases Grant 7,211,254 - Holroyd , et al. May 1, 2	2007-05-01
Interleukin-9 mutein peptides Grant 7,192,578 - Levitt , et al. March 20, 2	2007-03-20
Asthma associated factors as targets for treating atopic allergies including asthma and related disorders App 20040204578 - Holroyd, Kenneth J. ; et al.	2004-10-14
Asthma associated factors as targets for treating atopic allergies including asthma and related disorders App 20040076607 - Levitt, Roy Clifford ; et al.	2004-04-22
Nucleic acids encoding a chloride channel protein Grant 6,716,603 - Holroyd , et al. April 6, 2	2004-04-06
Methods of treating asthma with interleukin-9 receptor antibodies Grant 6,645,492 - Levitt , et al. November 11, 2	2003-11-11
Asthma associated factors as targets for treating atopic allergies including asthma and related disorders App 20030078409 - Holroyd, Kenneth J. ; et al.	2003-04-24
Asthma associated factors as targets for treating atopic allergies including asthma and related disorders App 20020146391 - Levitt, Roy Clifford ; et al.	2002-10-10
Methods of treating asthma with interleukin-9 antibodies Grant 6,261,559 - Levitt , et al. July 17, 2	2001-07-17
Analogues of magainin peptides containing D-amino acids Grant 5,792,831 - Maloy August 11, 1	1998-08-11
Biologically active peptides and uses therefor Grant 5,424,290 - Maloy , et al. June 13, 1	1995-06-13
Ion-channel forming peptides Grant 5,239,059 - Zasloff , et al. August 24, 1	1993-08-24
Antimicrobial amphiphilic peptides Grant 5,225,399 - Zasloff , et al. July 6, 1	1993-07-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.